Canada Life
VNE

Canada Life’s Veoneer, Inc. VNE Stock Holding History

Canada Life’s Portfolio VNE Stock Details VNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,507
Closed -$256K – 2502
2022
Q1 		$256K Sell
6,507
-299
-4% -$10.6K ﹤0.01% 1839
2021
Q4 		$240K Sell
6,806
-347
-5% -$12.3K ﹤0.01% 1844
2021
Q3 		$245K Sell
7,153
-309,411
-98% -$9.83M ﹤0.01% 1871
2021
Q2 		$7.3M Buy
316,564
+13,337
+4% +$317K 0.02% 667
2021
Q1 		$7.42M Buy
303,227
+23,619
+8% +$617K 0.02% 655
2020
Q4 		$5.95M Buy
279,608
+78,120
+39% +$1.48M 0.01% 745
2020
Q3 		$2.96M Buy
201,488
+26,278
+15% +$317K 0.01% 893
2020
Q2 		$1.87M Buy
175,210
+60,459
+53% +$593K ﹤0.01% 1109
2020
Q1 		$838K Buy
114,751
+52,149
+83% +$622K ﹤0.01% 1382
2019
Q4 		$970K Buy
62,602
+17,029
+37% +$274K ﹤0.01% 1509
2019
Q3 		$685K Buy
45,573
+23,172
+103% +$376K ﹤0.01% 911
2019
Q2 		$387K Buy
22,401
+5,859
+35% +$123K ﹤0.01% 1854
2019
Q1 		$377K Buy
16,542
+5,581
+51% +$155K ﹤0.01% 1716
2018
Q4 		$248K Sell
10,961
-17,033
-61% -$599K ﹤0.01% 1878
2018
Q3 		$1.54M Buy
+27,994
New +$1.44M ﹤0.01% 1331

Other funds holding VNE

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Canada Life's VNE Position: Q2 2022 in Review

Canada Life sold out of Veoneer, Inc. (VNE) in Q2 2022, closing a stake of 6,507 shares — an estimated $256K sold.

Canada Life first reported a position in VNE in Q3 2018 and held it in 15 quarters. The position peaked at $7.42M in Q1 2021. 1 fund tracked by Wall St. Rank holds VNE as of Q2 2022.

  • Canada Life reported no remaining Veoneer, Inc. position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 6,507 Veoneer, Inc. shares in Q2 2022, an estimated $256K.
  • Canada Life first reported a position in Veoneer, Inc. in Q3 2018 and held it in 15 quarters.
  • Canada Life's Veoneer, Inc. position peaked at $7.42M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Veoneer, Inc. as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.